MedPath

Electrical Patient Reported Outcome of Prostate Cancer RadioTherapy

Conditions
Prostate Cancer
Interventions
Other: electronic PROMs questionnaire
Registration Number
NCT05187026
Lead Sponsor
Helsinki University Central Hospital
Brief Summary

This is an observational study where prostate cancer related PROMs (EPIC-26) is collected using two different methods (by paper questionnaires and electronically) and patient experience and preference is asked.

Detailed Description

Prostate cancer patients that are treated with radiation therapy for local prostate cancer receive EPIC-26 before treatment and during follow-up. EPIC-26 is collected both traditionally using paper questionnaires and electronically. Patients experience and preference for these are asked.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
300
Inclusion Criteria
  • cT1-4N0M0, gleason 6-10, PSA < 100, WHO ≤ 2 prostate cancer eligible for radiation therapy
  • willing to complete EPIC-26 questionnaires both in paper and electronically
  • willing to consent for the study
Exclusion Criteria
  • not able to complete EPIC-26 both in paper and electronically

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
EPIC-26 follow-upelectronic PROMs questionnaireAll men will receive EPIC-26 in paper and also an electronic version.
Primary Outcome Measures
NameTimeMethod
preferencethrough study completion, an average of 1 year

patient preference for type of questionnaire (paper versus electronic)

Secondary Outcome Measures
NameTimeMethod
QoL as measured using the validated EPIC-26 questionnairethrough study completion, an average of 1 year

Patient QoL after RT (EPIC-26, scale 0-100)

Trial Locations

Locations (1)

Helsinki University Hospital

🇫🇮

Helsinki, Uusimaa, Finland

© Copyright 2025. All Rights Reserved by MedPath